Collectively, these results suggested that the combination of EGFR and CXCR4 expression in serum sEVs may serve as an independent marker for NSCLC diagnosis, monitoring, and prognosis prediction. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.